![A Novartis company AREDS 2 and U Bruce E. Onofrey, OD, RPh, FAAO, FOGS Professor, University of Houston UEI. - ppt download A Novartis company AREDS 2 and U Bruce E. Onofrey, OD, RPh, FAAO, FOGS Professor, University of Houston UEI. - ppt download](https://images.slideplayer.com/34/10157286/slides/slide_24.jpg)
A Novartis company AREDS 2 and U Bruce E. Onofrey, OD, RPh, FAAO, FOGS Professor, University of Houston UEI. - ppt download
![Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221343441300042X-gr2.jpg)
Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect
![Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221343441300042X-gr1.jpg)
Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect
![Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221343441300042X-gr3.jpg)